Curaspan Health Group president/CEO appointed to Epilepsy Therapy Project Board of Directors

NEWTON, Mass. — May 18, 2010 — Curaspan Health Group, a provider of secure electronic patient-transition networks for hospitals, post-acute providers and suppliers, today announced that president and CEO Thomas R. Ferry has joined the board of directors of the Epilepsy Therapy Project. Founded in 2002, the Epilepsy Therapy Project brings together scientific, business and community leaders dedicated to advancing new therapies for epilepsy.  

Epilepsy is a neurological disorder involving abnormal electrical activity in the brain. An estimated 3 million people nationwide have been diagnosed with epilepsy, including one of Ferry’s children. When poorly controlled or uncontrolled, this condition can lead to significant impairment and mortality. Approximately 200,000 new cases of epilepsy will be diagnosed in the United States this year, affecting as many people as breast cancer.

The Epilepsy Therapy Project provides clinical and critical product development funding, as well as scientific and business direction to promising new therapies and invests in programs and platforms that can take time and costs out of new therapy development.